FDA Panel Backs Acorda MS Drug; Post-OK Trials Only - BioWorld Online PDF Print
BioWorld OnlineBut due to the increased risk of seizures associated with the drug and concerns about the use of fampridine SR in patients with renal impairment, ...Acorda Therapeutics Announces Positive Vote by FDA Advisory Committee for

... read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.